Stocktoria
Grifols, S.A. GRF.MC
ES · Bolsa de Madrid · XMAD · stock · Healthcare · website
Grifols, S.A. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €7.5B | €7.2B | €6.6B | €6.1B |
| Gross profit | €2.9B | €2.8B | €2.5B | €2.2B |
| R&D expense | €426.0M | €384.0M | €395.0M | €361.1M |
| SG&A expense | €1.1B | €1.1B | €1.3B | €1.1B |
| Operating income | €1.3B | €1.2B | €718.0M | €679.0M |
| Interest expense | €576.0M | €602.0M | €516.0M | €444.5M |
| Income tax | €115.0M | €231.0M | €43.0M | €90.1M |
| Net income | €402.0M | €157.0M | €42.0M | €185.0M |
| EPS (diluted) | €0.59 | €0.23 | €0.09 | €0.31 |
| Operating cash flow | €1.0B | €902.0M | €217.0M | -€1.4M |
| Free cash flow | €624.0M | €530.0M | -€93.0M | -€394.3M |
| Cash & equivalents | €801.0M | €980.0M | €529.6M | €549.2M |
| Inventory | €3.3B | €3.6B | €3.5B | €3.2B |
| Goodwill | €6.8B | €7.4B | €6.8B | €7.0B |
| Total assets | €19.7B | €21.4B | €21.0B | €21.2B |
| Total debt | €9.6B | €10.1B | €11.0B | €9.8B |
| Total liabilities | €12.1B | €12.8B | €13.5B | €13.3B |
| Shareholders' equity | €5.3B | €5.9B | €5.4B | €5.6B |
| Share buybacks | — | €0 | €0 | €3.5M |
Growth · year-over-year · Revenue CAGR 7.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +4.3% | +9.4% | +8.7% | — |
| Net income growth | +156.1% | +273.8% | -77.3% | — |
| EPS growth | +156.5% | +155.6% | -71.0% | — |
| Free cash flow growth | +17.7% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · ES · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.